Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).
作者信息
Mandell Lionel A
机构信息
McMaster University, Hamilton, Ontario, Canada.
出版信息
Diagn Microbiol Infect Dis. 2002 Sep;44(1):65-7. doi: 10.1016/s0732-8893(02)00444-3.
Abstract
摘要
相似文献
1
Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).
Diagn Microbiol Infect Dis. 2002 Sep;44(1):65-7. doi: 10.1016/s0732-8893(02)00444-3.
2
Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
Diagn Microbiol Infect Dis. 2002 Sep;44(1):127-8. doi: 10.1016/s0732-8893(02)00450-9.
3
Oral gatifloxacin in outpatient community-acquired pneumonia: results from TeqCES, a community-based, open-label, multicenter study.门诊社区获得性肺炎口服加替沙星治疗：基于社区的开放标签多中心研究TeqCES的结果
Diagn Microbiol Infect Dis. 2002 Sep;44(1):85-91. doi: 10.1016/s0732-8893(02)00447-9.
4
Efficacy and safety of gatifloxacin in elderly outpatients with community-acquired pneumonia.加替沙星治疗老年社区获得性肺炎门诊患者的疗效与安全性
Diagn Microbiol Infect Dis. 2002 Sep;44(1):117-25. doi: 10.1016/s0732-8893(02)00465-0.
5
Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly.加替沙星用于老年人社区获得性急性呼吸道感染的治疗
Diagn Microbiol Infect Dis. 2002 Sep;44(1):109-16. doi: 10.1016/s0732-8893(02)00458-3.
6
An open label, multicenter, non-comparative study of the efficacy and safety of oral gatifloxacin in the treatment of community-acquired pneumonia: a Brazilian study in five centers.口服加替沙星治疗社区获得性肺炎的疗效和安全性的开放标签、多中心、非对照研究：巴西五个中心的研究
Braz J Infect Dis. 2003 Feb;7(1):62-8. doi: 10.1590/s1413-86702003000100007. Epub 2003 Dec 2.
7
Community-based treatment of acute uncomplicated bacterial rhinosinusitis with gatifloxacin.基于社区的加替沙星治疗急性非复杂性细菌性鼻-鼻窦炎
Otolaryngol Head Neck Surg. 2002 Sep;127(3):182-9. doi: 10.1067/mhn.2002.127590.
8
Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
J Chemother. 2004 Apr;16 Suppl 2:11-4. doi: 10.1080/1120009x.2004.11782367.
9
Clinical effect of gatifloxacin, 200 mg daily, on bacterial community-acquired pneumonia in the elderly.每日200毫克加替沙星治疗老年患者细菌性社区获得性肺炎的临床疗效
J Infect Chemother. 2005 Dec;11(6):274-7. doi: 10.1007/s10156-005-0410-2.
10
Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae.加替沙星用于治疗由肺炎链球菌引起的门诊社区获得性肺炎。
Diagn Microbiol Infect Dis. 2002 Sep;44(1):93-100. doi: 10.1016/s0732-8893(02)00448-0.
Zotero 插件